Skip to main content

Otimar Side Effects

Generic name: hydrocortisone / neomycin / polymyxin b otic

Medically reviewed by Drugs.com. Last updated on Apr 8, 2023.

Note: This document contains side effect information about hydrocortisone / neomycin / polymyxin b otic. Some dosage forms listed on this page may not apply to the brand name Otimar.

Applies to hydrocortisone/neomycin/polymyxin b otic: otic solution, otic suspension.

Serious side effects of Otimar

Along with its needed effects, hydrocortisone/neomycin/polymyxin b otic may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking hydrocortisone/neomycin/polymyxin b otic:

More common

Rare

Incidence not known

Other side effects of Otimar

Some side effects of hydrocortisone / neomycin / polymyxin b otic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

For Healthcare Professionals

Applies to hydrocortisone / neomycin / polymyxin b otic: otic solution, otic suspension.

Hypersensitivity

Rare (less than 0.1%): Application site hypersensitivity[Ref]

Dermatologic

Rare (less than 0.1%): Local exfoliative dermatitis, skin atrophy, telangiectasia , stria, exacerbation of underlying skin conditions (including eczema)

Frequency not reported: Folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, miliaria[Ref]

General

The most commonly reported side effect was hypersensitivity.[Ref]

Nervous system

Frequency not reported: Ototoxicity[Ref]

Immunologic

Frequency not reported: Secondary infection[Ref]

Local

Rare (less than 0.1%): Application site reaction including pain, irritation, edema, burning sensation, rash

Frequency not reported: Itching, dryness, stinging[Ref]

Renal

Frequency not reported: Nephrotoxicity[Ref]

References

1. Product Information. Cortisporin Otic (hydrocortisone/neomycin/polymyxin B otic). Monarch Pharmaceuticals Inc. 2022.

2. Cerner Multum, Inc. UK Summary of Product Characteristics.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.